Status:

UNKNOWN

Rehabilitative BCI in Acute Ischemic Stroke

Lead Sponsor:

Xuanwu Hospital, Beijing

Conditions:

Stroke, Acute

Eligibility:

All Genders

35-60 years

Phase:

NA

Brief Summary

In order to explore the role and expound the mechanism of rehabilitative brain computer interface (BCI)-based training (referred to as the Walk Again Neurorehabilitation protocol) in neurofunctional r...

Detailed Description

The participants will be randomly divided into experimental group and control group. The experimental group will receive BCI-based lower limb functional training, 30 minutes per time, 5 times per week...

Eligibility Criteria

Inclusion

  • The diagnosis of cerebral infarction conforms to the diagnostic criteria of "Chinese guidelines for diagnosis and treatment of acute ischemic stroke 2018".
  • 35 ≤ age ≤ 60 .
  • Onset (last-seen-well) time to randomization time from 24-72 hours.
  • First onset.
  • The lesion is assessed by MRI as a single subcortical infarction of the anterior circulation.
  • 5 ≤NIHSS≤15 (and 1 ≤6a/b≤3 ).
  • 1 ≤FAC functional walking scale score ≤ 3.
  • Signed informed consent from subject or legally authorized representative.

Exclusion

  • Unstable vital signs.
  • Progressive stroke.
  • Patients have received intravenous thrombolysis or endovascular treatment.
  • Cardiogenic cerebral embolism.
  • Presence of moderate or higher vascular stenosis or vulnerable plaque based on Imaging assessment.
  • With other diseases of the nervous system.
  • With serious diseases of other systems (severe circulatory system, respiratory system, motor system) and other diseases unsuitable for training, such as atrial fibrillation, heart failure, lung infection, severe liver or kidney insufficiency, lower extremity venous thrombosis.
  • Lower limb dysfunction caused by other reasons, such as fracture, lower limb deformity, etc.
  • With contraindications in imaging examinations, such as metal implantation, fear of claustrophobia, and severe obesity.
  • Patient who cannot cooperate with training, such as mental disorders, cognitive dysfunction, Mini-Mental State Examination (MMSE) \<21 points, etc.
  • Other reasons: alcoholism; pregnancy; skull defect; indwelling urinary catheter; vision defects affect training, etc.

Key Trial Info

Start Date :

January 16 2021

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 31 2021

Estimated Enrollment :

40 Patients enrolled

Trial Details

Trial ID

NCT04704427

Start Date

January 16 2021

End Date

December 31 2021

Last Update

January 11 2021

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.